News

First Subject Enrolled in Phase II/III Study of Eisai’s Anti-MTBR Tau Antibody E2814 for Dominantly Inherited Alzheimer’s Disease (DIAD), conducted by DIAN-TU

Eisai Co., Ltd. - Jan 19 2022

New Alzheimer’s prevention trial in young people

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE NEWS RELEASE - DEC 20 2021

$11.5 million commitment supports new Alzheimer’s prevention clinical trial

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE NEWS RELEASE - DEC 20 2021

International Alzheimer’s clinical trial to test two drugs in combination

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE NEWS RELEASE - NOV 8 2021

Global Incubator Seed Grants awarded

The Source, Washington University in St. Louis - Sept 23, 2021

The Search for a Drug to End Alzheimer’s

Some antiamyloids remove target plaques from the brain, yet don't seem to halt cognitive decline. Researchers are working to understand...

IEEE Pulse

Aiming at the Tangle’s Heart? DIAN-TU Trial to Torpedo Tau’s Core

ALZFORUM - MAR 18, 2021

Encouraging findings in Alzheimer’s prevention trial lead to the next phase

Neuroscience Research Australia (NeuRA) website - MAR 15, 2021

International Alzheimer’s clinical trial to test tau drugs

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE NEWS RELEASE - MAR 15 2021

Bateman, Diamond, Hultgren named to National Academy of Inventors

School of Medicine scientists honored for innovation

The Source, Washington University in St. Louis - December 8, 2020